1. Köbel, M, Kalloger, SE, Boyd, N, et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2008;5:e232.
Google Scholar | Crossref | Medline2. Curtis, C, Shah, SP, Chin, SF, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346-352.
Google Scholar | Crossref | Medline | ISI3. Guinney, J, Dienstmann, R, Wang, X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350-1356.
Google Scholar | Crossref | Medline | ISI4. Lockwood, WW, Wilson, IM, Coe, BP, et al. Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development. PLoS One. 2012;7:e37775.
Google Scholar | Crossref5. Sadanandam, A, Lyssiotis, CA, Homicsko, K, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med. 2013;19:619-625.
Google Scholar | Crossref | Medline | ISI6. Waks, AG, Winer, EP. Breast cancer treatment: a review. JAMA. 2019;321:288-300.
Google Scholar | Crossref | Medline7. Seligson, ND, Knepper, TC, Ragg, S, Walko, CM. Developing drugs for tissue-agnostic indications: a paradigm shift in leveraging cancer biology for prec on medicine. Clin Pharmacol Ther. 2021;109:334-342.
Google Scholar | Crossref | Medline8. Oberstein, PE, Olive, KP. Pancreatic cancer: why is it so hard to treat? Therap Adv Gastroenterol. 2013;6:321-337.
Google Scholar | SAGE Journals | ISI9. National Cancer Institute Surveillance, Epidemiology and ERP . Cancer stat facts: pancreatic cancer. 2021. Accessed May 30, 2021. https://seer.cancer.gov/statfacts/html/pancreas.html
Google Scholar10. Bailey, P, Chang, DK, Nones, K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47-52.
Google Scholar | Crossref | Medline | ISI11. Waddell, N, Pajic, M, Patch, AM, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518:495-501.
Google Scholar | Crossref | Medline | ISI12. Scarpa, A, Chang, DK, Nones, K, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543:65-71.
Google Scholar | Crossref | Medline13. O’Connor, K, Li-Chang, HH, Kalloger, SE, et al. Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma. Am J Surg Pathol. 2015;39:472-478.
Google Scholar | Crossref | Medline14. Naso, JR, Topham, JT, Karasinska, JM, et al. Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma. Cancer Med. 2021;10:1155-1165.
Google Scholar | Crossref | Medline15. Riazy, M, Kalloger, SE, Sheffield, BS, et al. Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma. Mod Pathol. 2015;28:1383-1389.
Google Scholar | Crossref | Medline16. Kalloger, SE, Riazy, M, Tessier-Cloutier, B, et al. A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine. J Pathol Clin Res. 2017;3:179-190.
Google Scholar | Crossref | Medline17. Tessier-Cloutier, B, Kalloger, SE, Al-Kandari, M, et al. Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma. BMC Cancer. 2017;17:618.
Google Scholar | Crossref | Medline18. Leo, JM, Kalloger, SE, Peixoto, RD, et al. Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups. J Clin Pathol. 2016;69:431-439.
Google Scholar | Crossref | Medline19. Wong, HL, Yang, KC, Shen, Y, et al. Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing. Cold Spring Harb Mol Case Stud. 2018;4:1-17.
Google Scholar | Crossref20. Zeggini, E, Gloyn, AL, Barton, AC, Wain, LV. Translational genomics and precision medicine: moving from the lab to the clinic. Science. 2019;365:1409-1413.
Google Scholar | Crossref | Medline21. Bleeker, SE, Moll, HA, Steyerberg, EW, et al. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol. 2003;56:826-832.
Google Scholar | Crossref | Medline | ISI22. Roberts, BS, Hardigan, AA, Moore, DE, et al. Discovery and validation of circulating biomarkers of colorectal adenoma by high-depth small RNA sequencing. Clin Cancer Res. 2018;24:2092-2099.
Google Scholar | Crossref | Medline23. Cristescu, R, Mogg, R, Ayers, M, et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science. 2018;362:80.
Google Scholar | Crossref | Medline24. Croner, LJ, Dillon, R, Kao, A, et al. Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects. Clin Proteomics. 2017;14:28.
Google Scholar | Crossref | Medline25. Half, E, Keren, N, Reshef, L, et al. Fecal microbiome signatures of pancreatic cancer patients. Sci Rep. 2019;9:16801.
Google Scholar | Crossref | Medline26. Riquelme, E, Zhang, Y, Zhang, L, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795-806.e12.
Google Scholar | Crossref | Medline27. Weersma, RK, Zhernakova, A, Fu, J. Interaction between drugs and the gut microbiome. Gut. 2020;69:1510-1519.
Google Scholar | Crossref | Medline28. Tang, Q, Jin, G, Wang, G, et al. Current sampling methods for gut microbiota: a call for more precise devices. Front Cell Infect Microbiol. 2020;10:151.
Google Scholar | Crossref | Medline29. Nissinen, SI, Roine, A, Hokkinen, L, et al. Detection of pancreatic cancer by urine volatile organic compound analysis. Anticancer Res. 2019;39:73-79.
Google Scholar | Crossref | Medline30. Renouf, DJ . Prospectively defining metastatic pancreatic ductal adenocarcinoma subtypes by comprehensive genomic analysis (PanGen). ClinicalTrials.gov. 2021. Accessed May 30, 2021. https://clinicaltrials.gov/ct2/show/NCT02869802
Google Scholar31. Langhof, H, Schwietering, J, Strech, D. Practice evaluation of biobank ethics and governance: current needs and future perspectives. J Med Genet. 2019;56:176-185.
Google Scholar | Crossref | Medline32. Wilbanks, BA, Berner, ES, Alexander, GL, Azuero, A, Patrician, PA, Moss, JA. The effect of data-entry template design and anesthesia provider workload on documentation accuracy, documentation efficiency, and user-satisfaction. Internet J Med Inform. 2018;118:29-35.
Google Scholar | Crossref | Medline